Status:
COMPLETED
PENG Block vs Intrathecal Morphine in Total Hip Arthroplasty
Lead Sponsor:
Kresimir Oremus, MD
Conditions:
Total Hip Arthroplasty
Postoperative Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare the impact of pericapsular nerve group (PENG) block to intrathecal morphine on postoperative analgesia, motor function and side effects in patients undergoing primary total hip arthroplasty...
Detailed Description
The study aims to confirm the non-inferiority of PENG block vs intrathecal morphine in patients undergoing total hip arthroplasty under spinal anesthesia. Non-inferiority will be assessed regarding ma...
Eligibility Criteria
Inclusion
- adult patients with osteoarthritis of the hip scheduled for primary total hip arthroplasty under spinal anesthesia able to provide written informed consent
Exclusion
- patient unwilling / unable to provide informed consent
- contraindications for any of the drugs and procedures included in the study protocol (allergies, local infection, coagulopathy)
- high risk for perioperative morbidity/mortality (ASA Physical Status Classification IV)
- preoperative use of strong opioid analgesia (due to hip pain or other acute/chronic pain condition)
- pregnancy
- substance abuse
- Post Randomization
Key Trial Info
Start Date :
April 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05308420
Start Date
April 3 2022
End Date
December 1 2022
Last Update
December 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akromion Special Hospital for Orthopedic Surgery
Krapinske Toplice, Croatia, 49217